Abstract |
Mycoplasmas are the smallest and simplest bacteria that lack a cell wall but have the capability of self-replication. Among them, Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia. The hallmark of mycoplasma respiratory diseases is the persistence of lung inflammation that involves both innate and adaptive immune responses. In recent years, a growing body of evidence demonstrates that IL-17 plays an important role in respiratory mycoplasma infection, and associates with the pathologic outcomes of infection, such as pneumonitis and asthma. Numerous studies have shown that a variety of cells, in particular Th17 cells, in the lung can secrete IL-17 during respiratory mycoplasma infection. In this article, we review the biological functions of distinct IL-17-producing cells in mycoplasma respiratory infection with a focus on the effect of IL-17 on the outcomes of infection.
|
Authors | Ying Luo, Cheng Li, Zhou Zhou, Zhande Gong, Cuiming Zhu, Aihua Lei |
Journal | Immunology
(Immunology)
Vol. 164
Issue 2
Pg. 223-230
(10 2021)
ISSN: 1365-2567 [Electronic] England |
PMID | 33930194
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Copyright | © 2021 John Wiley & Sons Ltd. |
Chemical References |
|
Topics |
- Animals
- Asthma
(immunology)
- Humans
- Interleukin-17
(immunology)
- Lung
(immunology)
- Mycoplasma Infections
(immunology)
- Mycoplasma pneumoniae
(immunology)
- Pneumonia
(immunology)
- Respiratory Tract Infections
(immunology)
|